The Procter & Gamble Company (NYSE:PG) Shares Bought by Edge Wealth Management LLC

Edge Wealth Management LLC grew its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 0.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,355 shares of the company’s stock after acquiring an additional 198 shares during the quarter. Procter & Gamble comprises approximately 2.0% of Edge Wealth Management LLC’s investment portfolio, making the stock its 20th biggest position. Edge Wealth Management LLC’s holdings in Procter & Gamble were worth $9,630,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of PG. HighPoint Advisor Group LLC purchased a new position in shares of Procter & Gamble during the 4th quarter worth $17,696,000. Dfpg Investments LLC raised its stake in shares of Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after acquiring an additional 424 shares during the period. Campbell Wealth Management lifted its holdings in shares of Procter & Gamble by 13.1% in the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock worth $291,000 after acquiring an additional 231 shares during the last quarter. Herold Advisors Inc. increased its holdings in Procter & Gamble by 2.2% in the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after purchasing an additional 581 shares during the last quarter. Finally, Metis Global Partners LLC raised its position in Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after purchasing an additional 15,599 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG traded down $0.83 during trading hours on Thursday, hitting $166.62. The company had a trading volume of 4,969,691 shares, compared to its average volume of 6,575,230. The business has a 50 day moving average of $165.28 and a 200-day moving average of $158.54. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $169.41. The company has a market cap of $393.25 billion, a PE ratio of 27.31, a price-to-earnings-growth ratio of 3.39 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.37 earnings per share. As a group, equities research analysts expect that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were given a dividend of $1.0065 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 annualized dividend and a yield of 2.42%. The ex-dividend date was Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Activity at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the completion of the sale, the chief executive officer now owns 4,004 shares in the company, valued at $634,634. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Balaji Purushothaman sold 28,369 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the transaction, the insider now directly owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the transaction, the chief executive officer now directly owns 4,004 shares in the company, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock worth $25,413,051 in the last quarter. Company insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on PG shares. Deutsche Bank Aktiengesellschaft dropped their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. Barclays increased their price target on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. BNP Paribas began coverage on shares of Procter & Gamble in a report on Monday. They issued an “outperform” rating and a $187.00 price objective for the company. StockNews.com upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $170.72.

Check Out Our Latest Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.